Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

PMV Pharmaceuticals, Inc.

NASDAQ: PMVP · Life Sciences · 3 alerts · CIK 1699382

Share price
$1.19Close, Nov 16
Market cap
$89.9M
Shares outstanding
75.53MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All PMV Pharmaceuticals, Inc. filings on SEC EDGAR ↗

9:00 AM ET 8-K
Executive Compensation

PMV Pharmaceuticals Executive Compensation

PMV Pharmaceuticals appointed Dr. Matthew Eckler to its Board of Directors, effective October 1, 2026. Dr. Eckler will receive an annual cash retainer of $40,000 and was granted an initial stock option award for 84,000 shares under the company's Outside Director Compensation Policy. The appointment comes as the company prepares for a planned NDA submission for rezatapopt in early 2027.

Counterparty
Dr. Matthew Eckler
Term
through 2029 Annual Meeting

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.